Overuse in cancer care: do European studies provide information useful to support policies?

Roberto Grilli, Valentina Chiesa

Research output: Contribution to journalReview article

Abstract

Health services overuse has been acknowledged as a relevant policy issue. In this study, we assessed the informative value of research on the quality of cancer care, exploring to what extent it is actually concerned with care overuse, thus providing policy-makers with sound estimates of overuse prevalence. We searched Medline for European studies, reporting information on the rate of use of diagnostic or therapeutic procedures/interventions in breast, colorectal, lung and prostate cancer patients, published in English between 2006 and 2016. Individual studies were classified with regards to their orientation towards overuse according to the quality metrics adopted in assessing rates of use of procedures and interventions.Out of 1882 papers identified, 100 accounting for 94 studies met our eligibility criteria, most of them on breast (n = 38) and colorectal (n = 30) cancer. Of these, 46 (49%) studies relied on process indicators allowing a direct measure of under- or overuse, the latter being addressed in 22 (24%) studies. Search for overuse in patterns of care did not increase over time, with overuse being measured in 24% of the studies published before 2010, and in only 13% of those published in 2015-2016. Information on its prevalence was available only for a relatively limited number of procedures/interventions. Overall, estimates of overuse tended to be higher for diagnostic procedures (median prevalence across all studies, 24%) than for drugs, surgical procedures or radiotherapy (median overuse prevalence always lower than 10%). Despite its increasing policy relevance, overuse is still an often overlooked issue in current European research on the quality of care for cancer patients.

Original languageEnglish
Pages (from-to)12
JournalHealth Research Policy and Systems
Volume16
Issue number1
DOIs
Publication statusPublished - Feb 20 2018

Fingerprint

Quality of Health Care
Neoplasms
Administrative Personnel
Research
Colorectal Neoplasms
Lung Neoplasms
Prostatic Neoplasms
Breast
Radiotherapy
Breast Neoplasms
Pharmaceutical Preparations
Therapeutics
Medical Overuse

Keywords

  • Europe
  • Health Policy
  • Humans
  • Medical Overuse
  • Neoplasms/diagnosis
  • Process Assessment (Health Care)
  • Quality of Health Care

Cite this

Overuse in cancer care : do European studies provide information useful to support policies? / Grilli, Roberto; Chiesa, Valentina.

In: Health Research Policy and Systems, Vol. 16, No. 1, 20.02.2018, p. 12.

Research output: Contribution to journalReview article

@article{e0e936478b304462bb081bd9b39e5e11,
title = "Overuse in cancer care: do European studies provide information useful to support policies?",
abstract = "Health services overuse has been acknowledged as a relevant policy issue. In this study, we assessed the informative value of research on the quality of cancer care, exploring to what extent it is actually concerned with care overuse, thus providing policy-makers with sound estimates of overuse prevalence. We searched Medline for European studies, reporting information on the rate of use of diagnostic or therapeutic procedures/interventions in breast, colorectal, lung and prostate cancer patients, published in English between 2006 and 2016. Individual studies were classified with regards to their orientation towards overuse according to the quality metrics adopted in assessing rates of use of procedures and interventions.Out of 1882 papers identified, 100 accounting for 94 studies met our eligibility criteria, most of them on breast (n = 38) and colorectal (n = 30) cancer. Of these, 46 (49{\%}) studies relied on process indicators allowing a direct measure of under- or overuse, the latter being addressed in 22 (24{\%}) studies. Search for overuse in patterns of care did not increase over time, with overuse being measured in 24{\%} of the studies published before 2010, and in only 13{\%} of those published in 2015-2016. Information on its prevalence was available only for a relatively limited number of procedures/interventions. Overall, estimates of overuse tended to be higher for diagnostic procedures (median prevalence across all studies, 24{\%}) than for drugs, surgical procedures or radiotherapy (median overuse prevalence always lower than 10{\%}). Despite its increasing policy relevance, overuse is still an often overlooked issue in current European research on the quality of care for cancer patients.",
keywords = "Europe, Health Policy, Humans, Medical Overuse, Neoplasms/diagnosis, Process Assessment (Health Care), Quality of Health Care",
author = "Roberto Grilli and Valentina Chiesa",
year = "2018",
month = "2",
day = "20",
doi = "10.1186/s12961-018-0287-z",
language = "English",
volume = "16",
pages = "12",
journal = "Health Research Policy and Systems",
issn = "1478-4505",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Overuse in cancer care

T2 - do European studies provide information useful to support policies?

AU - Grilli, Roberto

AU - Chiesa, Valentina

PY - 2018/2/20

Y1 - 2018/2/20

N2 - Health services overuse has been acknowledged as a relevant policy issue. In this study, we assessed the informative value of research on the quality of cancer care, exploring to what extent it is actually concerned with care overuse, thus providing policy-makers with sound estimates of overuse prevalence. We searched Medline for European studies, reporting information on the rate of use of diagnostic or therapeutic procedures/interventions in breast, colorectal, lung and prostate cancer patients, published in English between 2006 and 2016. Individual studies were classified with regards to their orientation towards overuse according to the quality metrics adopted in assessing rates of use of procedures and interventions.Out of 1882 papers identified, 100 accounting for 94 studies met our eligibility criteria, most of them on breast (n = 38) and colorectal (n = 30) cancer. Of these, 46 (49%) studies relied on process indicators allowing a direct measure of under- or overuse, the latter being addressed in 22 (24%) studies. Search for overuse in patterns of care did not increase over time, with overuse being measured in 24% of the studies published before 2010, and in only 13% of those published in 2015-2016. Information on its prevalence was available only for a relatively limited number of procedures/interventions. Overall, estimates of overuse tended to be higher for diagnostic procedures (median prevalence across all studies, 24%) than for drugs, surgical procedures or radiotherapy (median overuse prevalence always lower than 10%). Despite its increasing policy relevance, overuse is still an often overlooked issue in current European research on the quality of care for cancer patients.

AB - Health services overuse has been acknowledged as a relevant policy issue. In this study, we assessed the informative value of research on the quality of cancer care, exploring to what extent it is actually concerned with care overuse, thus providing policy-makers with sound estimates of overuse prevalence. We searched Medline for European studies, reporting information on the rate of use of diagnostic or therapeutic procedures/interventions in breast, colorectal, lung and prostate cancer patients, published in English between 2006 and 2016. Individual studies were classified with regards to their orientation towards overuse according to the quality metrics adopted in assessing rates of use of procedures and interventions.Out of 1882 papers identified, 100 accounting for 94 studies met our eligibility criteria, most of them on breast (n = 38) and colorectal (n = 30) cancer. Of these, 46 (49%) studies relied on process indicators allowing a direct measure of under- or overuse, the latter being addressed in 22 (24%) studies. Search for overuse in patterns of care did not increase over time, with overuse being measured in 24% of the studies published before 2010, and in only 13% of those published in 2015-2016. Information on its prevalence was available only for a relatively limited number of procedures/interventions. Overall, estimates of overuse tended to be higher for diagnostic procedures (median prevalence across all studies, 24%) than for drugs, surgical procedures or radiotherapy (median overuse prevalence always lower than 10%). Despite its increasing policy relevance, overuse is still an often overlooked issue in current European research on the quality of care for cancer patients.

KW - Europe

KW - Health Policy

KW - Humans

KW - Medical Overuse

KW - Neoplasms/diagnosis

KW - Process Assessment (Health Care)

KW - Quality of Health Care

U2 - 10.1186/s12961-018-0287-z

DO - 10.1186/s12961-018-0287-z

M3 - Review article

C2 - 29458403

VL - 16

SP - 12

JO - Health Research Policy and Systems

JF - Health Research Policy and Systems

SN - 1478-4505

IS - 1

ER -